# A Study of Prasugrel in Healthy Participants

> **NCT01648790** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 20 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Prasugrel ODT1 - Tablet
- **DRUG:** Prasugrel ODT2 - Tablet
- **DRUG:** Prasugrel ODT2 - Suspension

## Key facts

- **NCT ID:** NCT01648790
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2013-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01648790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01648790, "A Study of Prasugrel in Healthy Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01648790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*